Changes observed in functional activity of thiodisulphide antioxidant
system (TD AOS) in leukemia patients' blood are shown to depend in int
ensity and direction on the disease course and efficacy of relevant tr
eatment. TD AOS parameters which reflect body defenses may serve addit
ional criteria in the control of the treatment intensity.